Established amyloid-β pathology is unaffected by chronic treatment with the selective serotonin reuptake inhibitor paroxetine

Maurizio Severino, Mithula Sivasaravanaparan, Louise Ø Olesen, Christian U von Linstow, Athanasios Metaxas, Elena V Bouzinova, Asif Manzoor Khan, Kate L Lambertsen, Alicia A Babcock, Jan Bert Gramsbergen, Ove Wiborg, Bente Finsen

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

4 Citationer (Scopus)
67 Downloads (Pure)
OriginalsprogEngelsk
TidsskriftAlzheimer's & Dementia
Vol/bind4
Sider (fra-til)215-223
Antal sider9
ISSN1552-5260
DOI
StatusUdgivet - 2018

Fingerprint

Paroxetine
Serotonin Uptake Inhibitors
Amyloid
Pathology
Therapeutics
Serotonin
Alzheimer Disease
Presenilin-1
Serotonin Plasma Membrane Transport Proteins
Aptitude
Amyloid beta-Protein Precursor
Transgenic Mice
Antidepressive Agents
Enzyme-Linked Immunosorbent Assay
High Pressure Liquid Chromatography
Mortality
Brain

Emneord

    Citer dette

    Severino, M., Sivasaravanaparan, M., Olesen, L. Ø., von Linstow, C. U., Metaxas, A., Bouzinova, E. V., ... Finsen, B. (2018). Established amyloid-β pathology is unaffected by chronic treatment with the selective serotonin reuptake inhibitor paroxetine. Alzheimer's & Dementia, 4, 215-223. https://doi.org/10.1016/j.trci.2018.04.005
    Severino, Maurizio ; Sivasaravanaparan, Mithula ; Olesen, Louise Ø ; von Linstow, Christian U ; Metaxas, Athanasios ; Bouzinova, Elena V ; Khan, Asif Manzoor ; Lambertsen, Kate L ; Babcock, Alicia A ; Gramsbergen, Jan Bert ; Wiborg, Ove ; Finsen, Bente. / Established amyloid-β pathology is unaffected by chronic treatment with the selective serotonin reuptake inhibitor paroxetine. I: Alzheimer's & Dementia. 2018 ; Bind 4. s. 215-223.
    @article{c03da41268f84083ac5450608c97c75b,
    title = "Established amyloid-β pathology is unaffected by chronic treatment with the selective serotonin reuptake inhibitor paroxetine",
    keywords = "5,7-dihydroxytryptamine, Alzheimer's disease, Autoradiography, Cerebral amyloidosis, Monoamine, Neocortex, SERT occupancy, Selective serotonin reuptake inhibitor, Serotonin, Stereology, Transgenic mouse model, [ H]DASB",
    author = "Maurizio Severino and Mithula Sivasaravanaparan and Olesen, {Louise {\O}} and {von Linstow}, {Christian U} and Athanasios Metaxas and Bouzinova, {Elena V} and Khan, {Asif Manzoor} and Lambertsen, {Kate L} and Babcock, {Alicia A} and Gramsbergen, {Jan Bert} and Ove Wiborg and Bente Finsen",
    year = "2018",
    doi = "10.1016/j.trci.2018.04.005",
    language = "English",
    volume = "4",
    pages = "215--223",
    journal = "Alzheimer's & Dementia",
    issn = "1552-5260",
    publisher = "Elsevier",

    }

    Severino, M, Sivasaravanaparan, M, Olesen, LØ, von Linstow, CU, Metaxas, A, Bouzinova, EV, Khan, AM, Lambertsen, KL, Babcock, AA, Gramsbergen, JB, Wiborg, O & Finsen, B 2018, 'Established amyloid-β pathology is unaffected by chronic treatment with the selective serotonin reuptake inhibitor paroxetine' Alzheimer's & Dementia, bind 4, s. 215-223. https://doi.org/10.1016/j.trci.2018.04.005

    Established amyloid-β pathology is unaffected by chronic treatment with the selective serotonin reuptake inhibitor paroxetine. / Severino, Maurizio; Sivasaravanaparan, Mithula; Olesen, Louise Ø; von Linstow, Christian U; Metaxas, Athanasios; Bouzinova, Elena V; Khan, Asif Manzoor; Lambertsen, Kate L; Babcock, Alicia A; Gramsbergen, Jan Bert; Wiborg, Ove; Finsen, Bente.

    I: Alzheimer's & Dementia, Bind 4, 2018, s. 215-223.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

    TY - JOUR

    T1 - Established amyloid-β pathology is unaffected by chronic treatment with the selective serotonin reuptake inhibitor paroxetine

    AU - Severino, Maurizio

    AU - Sivasaravanaparan, Mithula

    AU - Olesen, Louise Ø

    AU - von Linstow, Christian U

    AU - Metaxas, Athanasios

    AU - Bouzinova, Elena V

    AU - Khan, Asif Manzoor

    AU - Lambertsen, Kate L

    AU - Babcock, Alicia A

    AU - Gramsbergen, Jan Bert

    AU - Wiborg, Ove

    AU - Finsen, Bente

    PY - 2018

    Y1 - 2018

    KW - 5,7-dihydroxytryptamine

    KW - Alzheimer's disease

    KW - Autoradiography

    KW - Cerebral amyloidosis

    KW - Monoamine

    KW - Neocortex

    KW - SERT occupancy

    KW - Selective serotonin reuptake inhibitor

    KW - Serotonin

    KW - Stereology

    KW - Transgenic mouse model

    KW - [ H]DASB

    UR - http://www.scopus.com/inward/record.url?scp=85048457883&partnerID=8YFLogxK

    U2 - 10.1016/j.trci.2018.04.005

    DO - 10.1016/j.trci.2018.04.005

    M3 - Journal article

    VL - 4

    SP - 215

    EP - 223

    JO - Alzheimer's & Dementia

    JF - Alzheimer's & Dementia

    SN - 1552-5260

    ER -